Symrise AG : A Prize for Beauty: Symrise receives Frost & Sullivan Award for its Eyelash Enhancing SymPeptide® 226EL

January 20, 2012 • 2011 European Personal Care Product Differentiation Excellence Award from Frost & Sullivan
• Scientifically proven improvement of appearance and fullness of eyelashes
• Joint Development with Therapeutic Peptides Inc

At the end of 2011, Symrise has received a Frost & Sullivan Award for its active ingredient SymPeptide® 226EL. The prize honors the product's eyelash enhancing properties. Symrise had developed the component with the help of its partner Therapeutic Peptides Inc (TPI) in 2009. Since then, it has shown proven efficacy in many cosmetic products.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry. The laureates come from a wide spectrum of industries, such as financial management services, mobile communication, healthcare and personal care.

This year, Symrise is among the 22 winners and receives the 2011 European Personal Care Product Differentiation Excellence Award from Frost & Sullivan. According to F&S, this prize goes to the company that has demonstrated excellence in developing unique product features and functionality, in achieving superior customization and in matching target market needs. The award lauds the brand perception of the uniqueness of the product.

"The use of SymPeptide® 226EL helps to improve the appearance of naturally beautiful and plentiful eyelashes, making the product unique in the market. Clinical studies show that it improves appearance and volume within two weeks. SymPeptide® 226EL is a lipo-oligopeptide having 5 amino acids and a fatty acid. The attached lipid promotes deeper penetration into the skin and hair follicles," notes Frost & Sullivan Vice President of Chemicals Shomik Majumdar. "Its lipophilic nature makes it highly effective, enabling it to easily reach the target site." "SymPeptide® 226EL does not cause skin irritation or discoloration," adds Research Analyst Dr Sujatha Vijayan. "It truly enhances the appearance of eyelashes."

Several studies prove that SymPeptide® 226EL helps provide luscious eyelashes with visible results in 2 weeks at the recommended use level. For instance in a study, when using SymPeptide® 226EL once daily, an improvement in  volume and fullness was substantiated up to 48% in just two weeks. The peptide in SymPeptide® 226EL supports the production of keratin, the major component found in hair and eyelashes. Keratin has been found to fight signs of ageing, while also acting as an eyelash appearance enhancer. It is colorless-to-beige, odorless and easy to apply.

SymPeptide® 226EL has been developed through a collaborative partnership with Therapeutic Peptides Incorporated in the USA. This partnership ensures Symrise the exclusive marketing of SymPeptide® 226EL along with other novel peptides for a wide range of cosmetic applications. To give customers an immediate understanding of the ingredient's application, the product will be marketed under SymPeptide® XLash in the future.

"For us, the Product Differentiation Excellence Award is a prestigious recognition of Symrise's accomplishments in the personal care market. It acknowledges our efforts to deliver excellence and best practice in the personal care market," outlines Dr. Gabriele Vielhaber, Global Head Cosmetic Ingredients and Innovation Life Essentials. "My special thanks go to my colleagues and our partners who have helped in the development and marketing of SymPeptide® 226EL."

Press contact:
Bernhard Kott
Phone: [phone]
E-mail: [e-mail]